Company intelligence / Profile preview

Connection Capital

United Kingdom

Ownership: Private
Development stage: Other

Overview

Connection Capital is a UK-based independent investment firm that offers clients access to alternative asset classes including private equity, private debt, alternative asset funds, and commercial property, and it has made a number of co‑investments in life sciences and pharmaceutical businesses and funds, but it is not itself a biotech or healthcare company.[8][13]

Industry: Investors

Partnerships

Co‑investment alongside Headway Capital and Gyrus Capital in Essential Pharma[3]Client investment alongside institutional investors including Bristol Myers Squibb and the European Investment Fund into Life Sciences Partners 6 (LSP 6) fund[1]

Beyond the preview

Go deeper on Connection Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Connection Capital.

Explore the full profile